AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 181 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4 | -20.0% | 157 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $5 | +25.0% | 157 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $4 | 0.0% | 157 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $4 | -99.9% | 157 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $4,000 | 0.0% | 157 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $4,000 | -20.0% | 157 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $5,000 | 0.0% | 157 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $5,000 | -28.6% | 157 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $7,000 | -22.2% | 157 | 0.0% | 0.00% | -50.0% |
Q2 2021 | $9,000 | +12.5% | 157 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $8,000 | +14.3% | 157 | 0.0% | 0.00% | +100.0% |
Q4 2020 | $7,000 | +40.0% | 157 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $5,000 | -37.5% | 157 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $8,000 | +33.3% | 157 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $6,000 | -14.3% | 157 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $7,000 | +40.0% | 157 | 0.0% | 0.00% | +100.0% |
Q3 2019 | $5,000 | -37.5% | 157 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $8,000 | -27.3% | 157 | 0.0% | 0.00% | -33.3% |
Q1 2019 | $11,000 | +57.1% | 157 | 0.0% | 0.00% | +50.0% |
Q4 2018 | $7,000 | -41.7% | 157 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $12,000 | -7.7% | 157 | 0.0% | 0.00% | -20.0% |
Q2 2018 | $13,000 | 0.0% | 157 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $13,000 | +44.4% | 157 | 0.0% | 0.01% | +66.7% |
Q4 2017 | $9,000 | -10.0% | 157 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $10,000 | +25.0% | 157 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $8,000 | -11.1% | 157 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $9,000 | +28.6% | 157 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $7,000 | -12.5% | 157 | 0.0% | 0.00% | -25.0% |
Q3 2016 | $8,000 | +14.3% | 157 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $7,000 | +16.7% | 157 | 0.0% | 0.00% | +33.3% |
Q1 2016 | $6,000 | -40.0% | 157 | 0.0% | 0.00% | -50.0% |
Q4 2015 | $10,000 | -9.1% | 157 | 0.0% | 0.01% | -14.3% |
Q3 2015 | $11,000 | -35.3% | 157 | 0.0% | 0.01% | -30.0% |
Q2 2015 | $17,000 | +13.3% | 157 | 0.0% | 0.01% | +11.1% |
Q1 2015 | $15,000 | – | 157 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |